Perspectives on Recent Progress in Focused Ultrasound Immunotherapy

Natasha D Sheybani1, Richard J Price1

  • 1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA.

Theranostics
|November 8, 2019
PubMed
Summary

Focused ultrasound (FUS) is emerging as a promising immunotherapy adjuvant for solid tumors. Recent clinical trials and research highlight its potential to overcome T cell infiltration challenges, improving cancer treatment accessibility.

Related Concept Videos